Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphangioleiomyomatosis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 cyclopia sequence 6 Neoplasms 5 Polycystic Ovary Syndrome 3 Multiple Myeloma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Obesity 2 Neoplasms, Plasma Cell 2 Hematologic Diseases 2 Fatigue 2 Depression 2 Weight Loss 1 Warts 1 Vomiting 1 Vitamin D Deficiency 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Sleepiness 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Prostatic Intraepithelial Neoplasia 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1

Interventions

Sirolimus 6 Everolimus 3 saracatinib 1 Urination 1 Sugars 1 Simvastatin 1 Resveratrol 1 Octreotide 1 Letrozole 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Doxycycline 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01353209 2024-04-17

TRAIL

University of Cincinnati

Phase 2 Completed

17 enrolled 13 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡